Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

RioCan Real Estate Investment Trust T.REI.UN

Alternate Symbol(s):  RIOCF

RioCan Real Estate Investment Trust is a Canada-based real estate investment trust. The Company owns, manages and develops retail-focused, mixed-use properties. Its portfolio includes leasing, development, and residential. The Company’s properties are held by various tenants, such as grocery, pharmacy, liquor, personal services, and specialty and value retailers. Its portfolio comprises approximately 187 properties with an aggregate net leasable area of approximately 33 million square feet. Its properties include 1293 Bloor Street West; 145 Woodbridge Avenue; 1556 Bank Street; 1650 -1660 Carling Avenue; 1860 Bayview; 1946 Robertson Road; 2422 Fairview Street, and others. Its properties for commercial lease, including grocery anchored, open air, mixed-use/urban, and enclosed centers. Its residential brand, RioCan Living, delivers purpose-built rental units and condos. 1293 Bloor Street West is located at the intersection of Lansdowne Ave & Bloor Street in Toronto.


TSX:REI.UN - Post by User

Comment by Covidruinedmeon Nov 17, 2020 7:17am
69 Views
Post# 31912799

RE:RE:RE:RE:RE:RE:RE:RE:RE:Riocan has always been a $20+ stock

RE:RE:RE:RE:RE:RE:RE:RE:RE:Riocan has always been a $20+ stock
BlueGuitar1 wrote: FDA approval is NEVER a straight line.  You do realize that these are double blind studies and half get the vaccine and the other half get saline.  Then they are released into the public to see who gets the disease.  In addition, these vaccines haven't even been tested in adolescents or children yet. 

The N is big enough but the time frame is too short.  All I am saying is that the time frame is too short so don't expect a straight line recovery.  There are a lot of surprises to come. 


like i said, educate yourself first or you make a fool out of yourelf, timeframe is short? what does time frame has anything to do with phase 3 ? this isnt a safely phase, thats phase 1 and animal trials then the safetly analysis goes on for another 2 to 3 years while the vaccibe is disturbuted to the public. this is the effacy trial and it has nothing to do with timeframe. the happened quick because the virus is everywhere in USA. if the trial was only in china you wouldnt be getting any result at all.
Bullboard Posts